OncoPulse

Seu PubMed Oncológico

Busca em tempo real nos principais periódicos de oncologia indexados no PubMed. Resumos clínicos gerados por IA em português.

5,113 artigos encontrados
Ordenar por:
Melanoma
Journal Article

Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

Campbell K, Chen D, Bustami Z et al.Cancer Discov2026 Apr
Leukemia
Journal Article

AI-powered Deep Visual Proteomics reveals critical molecular transitions in pancreatic cancer precursors.

Min J, Schweizer L, Zonderland G et al.Cancer Discov2026 Apr
Leukemia
Journal Article

Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockade.

Blagg J, Riou P, Hervieu A et al.Cancer Discov2026 Apr
Lung Cancer
Journal Article

Stress Tested: Aging Rewires Tumors for Metastatic Spread Through Activation of the Integrated Stress Response.

Fane M, Zabransky DCancer Res2026 Apr
Breast Cancer
Journal Article

Targeting DNA Polymerase Epsilon Induces Tumor Clearance and Activates an NF-κB-Mediated Inflammatory Response in Triple Negative Breast Cancer.

Sher E, Fujihara K, Tao A et al.Cancer Res2026 Apr
Leukemia
Journal Article

SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilities.

Pelzer B, Meydan C, Spiegel I et al.Cancer Discov2026 Apr
Leukemia
Journal Article

scSurvival: Single-Cell Survival Analysis of Clinical Cancer Cohort Data at Cellular Resolution.

Ren T, Zhao F, Chen C et al.Cancer Discov2026 Apr
Melanoma
Journal Article

Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study.

Bentebibel S, McGrail D, Kochat V et al.Cancer Discov2026 Apr
Leukemia
Journal Article

PF4/Heparin-Nonbinding Platelet-Activating Antibodies in Heparin-Induced Thrombocytopenia.

Zhou L, Cao A, Zhu W et al.Blood2026 Apr
Leukemia
Journal Article

Refined classification and phenotype-driven analysis of PIEZO1 variants in hereditary red cell and iron disorders.

Rosato B, Marra R, Martone S et al.Blood2026 Apr
Leukemia
Journal Article

Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study.

Budde L, Kamdar M, Assouline S et al.Blood2026 Apr
Leukemia
Journal Article

Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesis.

Courbon G, Thomas J, J Duque E et al.Blood2026 Apr
Oncologia Geral
Journal Article

Preventing Pregnancy-Related Cardiovascular Disease Burden: A Report From the National Academies of Sciences, Engineering, and Medicine.

Bond R, Debbink M, Geller A et al.JAMA2026 Apr
Oncologia Geral
Journal Article

Direct Immunotherapy Injection Shrinks Oral Precancers.

Cancer Discov2026 Apr
Oncologia Geral
Journal Article

Wildfire Smoke Exposure Associated with Increased Cancer Risk.

Cancer Discov2026 Apr
Leukemia
Journal Article

A sensory system for mating in octopus.

Villar P, Jiang H, Shugaeva T et al.Science2026 Apr
Oncologia Geral
Journal Article

IL-22 from enteroendocrine cells promotes early-life gut motility in zebrafish through the microbiota.

Rabahi S, Maurin L, Marachlian E et al.Science2026 Apr
Oncologia Geral
Journal Article

maundy.

Ho LJAMA2026 Apr
Oncologia Geral
Journal Article

Poetry and Service Learning in Medicine.

Roberts K, Campo RJAMA2026 Apr
Lung Cancer
Journal Article

Elisrasib Elicits Clinical Benefit in KRASG12C-mutant NSCLC.

Cancer Discov2026 Apr
Página 1 de 50

TribeMD Assist

Integre o OncoPulse ao seu fluxo clínico diário

TribeMD Assist conecta literatura científica atualizada, prontuário eletrônico e IA clínica em um único sistema para o oncologista moderno.

Conhecer o TribeMD Assist →

+8.000 médicos já usam. Sem cartão de crédito.

Dados fornecidos pelo PubMed / NCBI via E-utilities API. Os resumos gerados por IA são auxiliares e não substituem a leitura do artigo original.
Oncologia Brasil Logo

Oncologia Brasil - Portal 2.0 De Tecnologia e IA na Oncologia. Integrando guidelines internacionais, ferramentas de inteligência artificial e as últimas atualizações científicas para otimizar a prática clínica do oncologista moderno.

Sociedades Oficiais

Aviso Legal: Este portal é destinado exclusivamente a profissionais de saúde. As ferramentas de IA, guidelines e informações aqui contidas são para fins educacionais e de suporte à decisão clínica, não substituindo o julgamento médico independente. Nenhuma ferramenta apresentada substitui a avaliação médica presencial.

© 2026 Oncologia Brasil. Todos os direitos reservados.